Skip to content

Research on Key Integrative Chinese and Western Medicine Technologies for Monitoring the Onset of Chronic Coronary Syndrome

Research on Key Integrative Chinese and Western Medicine Technologies for Monitoring the Onset of Chronic Coronary Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002194
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-19
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Coronary Syndrome

Interventions

Experiment Group:Integrated in-hospital and out-of-hospital diagnostic and therapeutic model
Control Group:The conventional treatment model refers to the Western medicine Guidelines for the Diagnosis and Treatment of Stable Coronary Heart Disease (2018), the Guidelines for the Primary Diagnos

Sponsors

Xiyuan Hospital of CACMS
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Study 3:Patients meeting the diagnostic criteria for chronic coronary syndrome (CCS) as defined in the 2024 Guidelines for the Diagnosis and Management of Chronic Coronary Syndrome issued by the Chinese Society of Cardiology, Chinese Medical Association.

Exclusion criteria

Exclusion criteria: Study 3:Within 1 month after acute myocardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG);Severe hematological diseases;Patients with malignant tumors or a history of organ transplantation;Patients with major psychiatric disorders or significant cognitive impairment;Patients deemed unsuitable for participation by the investigators.

Design outcomes

Primary

MeasureTime frame
demographic indicators;Angiography Computed Tomography(CTA);Seattleanginaquestionnaire(SAQ);The MOS 36-item short-form health survey(SF-36);

Secondary

MeasureTime frame
Echocardiography;Blood lipids;Blood glucose;Hypersensitive C-reactive protein(CRP);Electrocardiogram(ECG);Indicators of TCM syndromes;

Countries

China

Contacts

Public ContactZhuye Gao

Xiyuan Hospital of CACMS

zhuyegao@126.com13161267972

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026